These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6525902)

  • 1. [Propranolol in the primary therapy of thyrotoxicosis].
    Kuang YL
    Zhonghua Nei Ke Za Zhi; 1984 Jan; 23(1):31-3, 63. PubMed ID: 6525902
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of propranolol on thyroid hormones and oxygen consumption in thyrotoxicosis.
    Saunders J; Hall SE; Crowther A; Sönksen PH
    Clin Endocrinol (Oxf); 1978 Jul; 9(1):67-72. PubMed ID: 679503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperthyroidism after propranolol withdrawal.
    Shenkman L; Podrid P; Lowenstein J
    JAMA; 1977 Jul; 238(3):237-9. PubMed ID: 577524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of oxprenolol, acebutolol and propranolol on thyroid hormones in hyperthyroid subjects.
    Jones MK; John R; Jones GR
    Clin Endocrinol (Oxf); 1980 Oct; 13(4):343-7. PubMed ID: 7438476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propranolol in the treatment of thyrotoxicosis. A randomized double-blind study.
    Kvetny J; Frederikesen PK; Jacobsen JG; Haas V; Feldt-Rasmussen U; Date J
    Acta Med Scand; 1981; 209(5):389-92. PubMed ID: 7018181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propranolol as primary therapy for thyrotoxicosis.
    Mazzaferri EL; Reynolds JC; Young RL; Thomas CN; Parisi AF
    Arch Intern Med; 1976 Jan; 136(1):50-6. PubMed ID: 1108824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics in drug therapy. I: Propranolol hydrochloride as adjunct therapy in the treatment of thyrotoxicosis.
    Robayo JR
    Am J Hosp Pharm; 1976 Feb; 33(2):169-73. PubMed ID: 56890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary report on the use of propranolol in thyrotoxicosis: I. Effect on serum thyroxine, triiodothyronine and reverse triiodothyronine concentrations.
    Tevaarwerk GJ; Malik MH; Boyd D
    Can Med Assoc J; 1978 Aug; 119(4):350-1, 360. PubMed ID: 688126
    [No Abstract]   [Full Text] [Related]  

  • 9. Propranolol for the preoperative preparation of patients with thyrotoxicosis.
    Caswell HT; Marks AD; Channick BJ
    Surg Gynecol Obstet; 1978 Jun; 146(6):908-10. PubMed ID: 653566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical manifestations of hyperthyroidism after treatment with selective beta 1 adrenoceptor blocking agents.
    Shikara MM; Polena S; Solinas A; Sanghvi K; Gintautas J
    Proc West Pharmacol Soc; 2003; 46():125-6. PubMed ID: 14699906
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of R- versus S-propranolol on the peripheral thyroid hormone metabolism of hyperthyroid patients].
    Buchinger W; Lindner W; Lind P; Rath M; Langsteger W; Klima G; Költringer P; Eber O
    Acta Med Austriaca; 1988; 15 Suppl 1():62-3. PubMed ID: 3176825
    [No Abstract]   [Full Text] [Related]  

  • 12. The influence of pre-operative drug therapy on lymphoid tissue in patients with primary thyrotoxicosis.
    Simpson JG; Young RJ; Gray ES; Nicol AG; Michie W; Pegg CA; Beck JS
    J Pathol; 1973 Jan; 109(1):P8. PubMed ID: 4719742
    [No Abstract]   [Full Text] [Related]  

  • 13. Propranolol and the hypercalcaemia of thyrotoxicosis.
    Feely J
    Acta Endocrinol (Copenh); 1981 Dec; 98(4):528-32. PubMed ID: 7304079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Propranolol treatment in thyrotoxicosis].
    Cullhed I; Parrow A
    Lakartidningen; 1969 Sep; 66(39):3961-5. PubMed ID: 5384300
    [No Abstract]   [Full Text] [Related]  

  • 15. [Propranolol treatment of thyrotoxicosis].
    Karlberg B
    Lakartidningen; 1970 Dec; 67(50):5917-22. PubMed ID: 4395268
    [No Abstract]   [Full Text] [Related]  

  • 16. [Blocking of adrenergic beta receptors with propranolol in the treatment of thyrotoxicosis].
    Felt V
    Cas Lek Cesk; 1969 Sep; 108(38):1124-7. PubMed ID: 5810135
    [No Abstract]   [Full Text] [Related]  

  • 17. [The treatment of thyrotoxicosis with beta-blocking agents].
    Dogliotti L; Fonzo D; Lauro R; De Martinis C
    Minerva Med; 1971 Oct; 62(77):3679-84. PubMed ID: 4398567
    [No Abstract]   [Full Text] [Related]  

  • 18. Rational management of thyroid auto-immune disease.
    Adams DD
    N Z Med J; 1974 Dec; 80(529):486-9. PubMed ID: 4141486
    [No Abstract]   [Full Text] [Related]  

  • 19. Propranolol and thyroid resection for thyperthyroidism.
    Anderberg B; Kågedal B; Nilsson OR; Smeds S; Tegler L; Gillquist J
    Acta Chir Scand; 1979; 145(5):297-303. PubMed ID: 43060
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hypercalcemia as first manifestation of thyrotoxicosis (author's transl)].
    Webb Youdale S; Gatell Artigas JM; Soriano Marín E; Garcíca San Miquel J
    Med Clin (Barc); 1980 Feb; 74(3):107-8. PubMed ID: 7366271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.